The ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavir.

OBJECTIVE: The transfer of abacavir, a new nucleoside inhibitor, and amprenavir, a new protease inhibitor, used for the treatment of human immunodeficiency virus, has been studied in the ex vivo human placental model. METHODS: The ex vivo human placental model used C14 antipyrine to determine the tr...

Descripción completa

Detalles Bibliográficos
Autor principal: Bawdon, R E
Formato: Texto
Lenguaje:English
Publicado: 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784821/
https://www.ncbi.nlm.nih.gov/pubmed/9972485
http://dx.doi.org/10.1002/(SICI)1098-0997(1998)6:6<244::AID-IDOG4>3.0.CO;2-B

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784821/
https://www.ncbi.nlm.nih.gov/pubmed/9972485
http://dx.doi.org/10.1002/(SICI)1098-0997(1998)6:6<244::AID-IDOG4>3.0.CO;2-B

Ejemplares similares